Amylyx Pharmaceuticals (AMLX) EPS (Diluted) (2021 - 2026)
Powered by 
Analysis
Amylyx Pharmaceuticals (AMLX) EPS (Diluted) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 212.35 Bn | 198.36 Bn | 7.24 Bn | 4.37 |
| 2 | Gilead Sciences | 181.19 Bn | 178.01 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 132.48 Bn | 124.62 Bn | 2.84 Bn | 4.31 |
| 4 | Regeneron Pharmaceuticals | 82.59 Bn | 74.60 Bn | 3.93 Bn | 12.23 |
| 5 | Argenx Se | 61.45 Bn | 56.27 Bn | 1.37 Bn | 7.15 |
| 6 | Moderna | 54.89 Bn | 49.75 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 34.21 Bn | 30.90 Bn | 992.69 Mn | 1.19 |
| 8 | Biogen | 31.38 Bn | 30.10 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 29.81 Bn | 29.81 Bn | 1.16 Mn | -0.40 |
| 10 | Amylyx Pharmaceuticals | 3.70 Bn | 3.70 Bn | - | -0.39 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.39 |
| Mar 31, 2026 | -0.37 |
| Dec 31, 2025 | -0.03 |
| Sep 30, 2025 | -0.37 |
| Jun 30, 2025 | -0.46 |
| Mar 31, 2025 | -0.42 |
| Dec 31, 2024 | 0.37 |
| Sep 30, 2024 | -1.07 |
| Jun 30, 2024 | -1.07 |
| Mar 31, 2024 | -1.75 |
| Dec 31, 2023 | 0.06 |
| Sep 30, 2023 | 0.30 |
| Jun 30, 2023 | 0.31 |
| Mar 31, 2023 | 0.02 |
| Dec 31, 2022 | -0.75 |
| Sep 30, 2022 | -0.92 |
| Jun 30, 2022 | -0.93 |
| Mar 31, 2022 | -0.93 |
| Dec 31, 2021 | -4.30 |
| Sep 30, 2021 | -3.42 |